Maternal phenylketonuria syndrome

Maternal phenylketonuria (PKU) syndrome is not a genetic disorder of the affected child itself, but rather a teratogenic condition that occurs when a fetus is exposed to elevated levels of phenylalanine during pregnancy because the mother has phenylketonuria (PKU). Women with PKU who do not maintain strict dietary control of phenylalanine levels before and during pregnancy expose their developing fetus to toxic concentrations of this amino acid, which crosses the placenta and accumulates at levels higher than in the maternal blood. The fetus does not need to have PKU itself to be affected. The syndrome primarily affects the developing brain, heart, and craniofacial structures. Key clinical features in the affected offspring include intellectual disability (often severe), microcephaly, intrauterine growth restriction, low birth weight, congenital heart defects (particularly conotruncal malformations and septal defects), and characteristic facial dysmorphism. The severity of the syndrome correlates with the degree and duration of maternal hyperphenylalaninemia during pregnancy, with the first trimester being the most critical period for organogenesis-related damage. The condition is entirely preventable through strict maternal dietary phenylalanine restriction, ideally beginning before conception and maintained throughout pregnancy, with target maternal blood phenylalanine levels generally kept below 360 µmol/L (6 mg/dL). Women with PKU who are planning pregnancy should work closely with metabolic specialists and dietitians to achieve and maintain metabolic control. Newborn screening programs that identify PKU in females are essential for long-term counseling about the risks of maternal PKU syndrome in future pregnancies. Once the child is born with features of maternal PKU syndrome, the damage is irreversible, and management is supportive, focusing on developmental interventions, cardiac care if needed, and educational support.

Data sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Common questions about Maternal phenylketonuria syndrome